ICD-10 Coding for Mast Cell Activation Syndrome(C94.3, C94.3P, D89.4)
Learn about ICD-10 coding for Mast Cell Activation Syndrome (MCAS), including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Mast Cell Activation Syndrome
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D89.41 | Mast cell activation syndrome, unspecified | Use when MCAS is confirmed but not specified as secondary or idiopathic. |
|
| D89.43 | Secondary mast cell activation syndrome | Use when MCAS is secondary to another documented condition. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMast Cell Activation Syndrome
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Mast Cell Activation Syndrome.
Failing to document multi-organ involvement.
Impact
Clinical: May lead to misdiagnosis or incomplete treatment., Regulatory: Non-compliance with diagnostic criteria., Financial: Potential for claim denials.
Mitigation
Ensure comprehensive documentation of all affected systems.
Using unspecified codes when specific codes are available.
Impact
Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health records.
Mitigation
Ensure documentation supports the use of specific codes like D89.43 or D89.49.
Documentation of tryptase levels
Impact
Lack of documented tryptase levels can trigger audits.
Mitigation
Ensure all episodes have corresponding tryptase documentation.